Our data suggest that even with the higher dose of synthetic oxytocin administered to women with PPH, SSC + BF may be able to assist the system so that the negative impact of high doses of synthetic oxytocin can be minimized and can be used as an adjunct therapy to reduce severity of blood loss in women with PPH. Here, OXT is linked to pulmonary arterial hypertension.